Serum enzymes associated with cholestasis

Clinics in Liver Disease

Volumn 8, Issue 1, 2004, Pages 41-54

  Sotil, Eva U ^a   Jensen, Donald M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE; ISOENZYME;

CHOLESTASIS; CLINICAL EXAMINATION; DISEASE COURSE; ENZYME ACTIVITY; EVALUATION; HUMAN; MOLECULAR GENETICS; REVIEW;

ALKALINE PHOSPHATASE; CHOLESTASIS; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; NUCLEOTIDASES;

EID: 1642303153     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(03)00136-3     Document Type: Review

References (52)

1. Henny J., Schiele F. Alkaline phosphatase. Siest G., Henny J., Schiele F., Young D.S. Interpretation of clinical laboratory tests. Reference values and their biological variation. 1985;96-118 Biomedical Publications, Foster City (CA).
2. Moss D.W., Henderson A.R., Kachmar J.F. Enzymes. Tietz N. Fundamentals of clinical chemistry. 3rd edition:1987;346-417 WB Saunders, Philadelphia.
3. Moss D.W. Physicochemical and pathophysiological factors in the release of membrane-bound alkaline phosphate from cells. Clin Chim Acta. 257:1997;133-140.
4. Van Hoof V.O., Deng J.T., De Broe M.E. How do plasma membranes reach the circulation? Clin Chim Acta. 266:1997;23-31.
5. Kaplan M.M. Alkaline phosphatase. Gastroenterology. 62(3):1972;452-468.
6. Clubb J.S., Neale F.C., Posen S. The behavior of infused human placental alkaline phosphatase in human subjects. J Lab Clin Med. 66(3):1965;493-507.
7. Harris H. The human alkaline phosphatase: what we know and what we don't know. Clin Chim Acta. 186:1989;133-150.
8. Weiss M.J., Ray K., Henthorn P.S., Lamb B., Kadesch T., Harris H. Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem. 263(24):1988;12002-12010.
9. Pratt D.S., Kaplan M.M. Evaluation of the liver: laboratory tests. Schiff E.R., Sorrell M.F., Maddrey W.C. Schiff's diseases of liver. 8th edition:1999;205-244 Lippincott-Raven, Philadelphia.
10. Poelstra K., Bakker W.W., Klok P.A., Hardonk M.J., Meijer D.K.F. A physiologic function for alkaline phosphatase: endotoxin detoxification. Lab Invest. 76:1997;319-327.
11. Alvaro D., Benedetti A., Marucci L., Monache M.D., Monterubbianesi R., Di Cosimo E.et al. The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat. Hepatology. 32:2000;174-184.
12. Iqbal S.J., Davies T., Holland S., Manning T., Whittaker P. Alkaline phosphatase isoenzymes and clinical features in hypophosphatasia. Ann Clin Biochem. 37:2000;775-780.
13. Manolio T.A., Burke G.L., Savage P.J., Jacobs D.R. Jr., Sidney S., Wagenknecht L.E.et al. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem. 38:1992;1853-1859.
14. Brensilver H.L., Kaplan M.M. Significance of elevated liver alkaline phosphatase in serum. Gastroenterology. 68:1975;1556-1562.
15. Shaver W.A., Bhatt H., Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology. 6:1986;859-863.
16. Panigrahi K., Delmas P.D., Singer F., Ryan W., Reiss O., Fisher R.et al. Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem. 40(5):1994;822-828.
17. Romagnoli E., Minisola G., Carnevale V., Scillitani A., Frusciante V., Aliberti G.et al. Assessment of serum total and bone alkaline phosphatase measurement in clinical practice. Clin Chem Lab Med. 36:1998;163-168.
18. Narayanan S. Alkaline phosphatase as tumor marker. Ann Clin Lab Sci. 13:1983;33-36.
19. Fishman W.H. Clinical and biological significance of an isozyme tumor marker-PLAP. Clin Biochem. 20:1987;387-392.
20. Fishman W.H. Immunology and biochemistry of the Regan isoenzyme. Prostate. 1:1980;399-410.
21. Hatoff D.E., Hardison W.G.M. Induced synthesis of alkaline phosphatase by bile acids in rat liver cell culture. Gastroenterology. 77:1979;1062-1067.
22. Komoda T., Kumegawa M., Yajima T., Tamura G., Alpers D.H. Induction of rat hepatic and intestinal alkaline phosphatase activity produced by bile from bile duct-ligated animals. Am J Physiol. 246:1984;G393-G400.
23. Seetharam S., Sussman N.L., Komoda T., Alpers D.H. The mechanism of elevated alkaline phosphatase activity after bile duct ligation in the rat. Hepatology. 6(3):1986;374-380.
24. Hatoff D.E., Hardison W.G.M. Bile acid-dependent secretion of alkaline phosphatase in rat bile. Hepatology. 2(4):1982;433-439.
25. Kaplan M.M. Serum alkaline phosphatase-another piece is added to the puzzle. Hepatology. 6:1986;526-528.
26. Siest G., Schiele F., Artur Y. Gamma-glutamyltransferase. Interpretation of clinical laboratory tests. Reference values and their biological variation. 1985;235-252 Biomedical Publications, Foster City (CA).
27. Rosalki S.B. Gamma-glutamyl transpeptidase. Adv Clin Chem. 17:1975;53-107.
28. Nemesanszky E., Lott J. Gamma-glutamyltransferase and its isoenzymes: progress and problems. Clin Chem. 31(6):1985;797-803.
29. Reichling J.J., Kaplan M.M. Clinical use of serum enzymes in liver disease. Dig Dis Sci. 33(12):1988;1601-1614.
30. Shaw L.M., Stromme J.H., London J.L., Theodorsen L. International Federation of Clinical Chemistry, Scientific Committee, Analytical Section. IFCC methods for the measurement of catalytic concentration of enzymes. Part 4. IFCC method for gamma-glutamyltransferase. J Clin Chem Clin Biochem. 21(10):1983;633-646.
31. Ruppin D.C., Frydman M.R., Lunzer M.R. Value of serum gamma-glutamyltransferase activity in the diagnosis of hepatobiliary disease. Med J Aust. 1:1982;421-424.
32. Cuschieri A., Barker P.R. Gamma-glutamyl transpeptidase in hepatobiliary disease-value as an enzymatic liver function test. Br J Exp Pathol. 55:1974;110-115.
33. Bulle F., Mavier P., Zafrani E.S., Preaux A., Lescs M.C., Siegrist S.et al. Mechanism of γ-glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: a histochemical, biochemical and molecular approach. Hepatology. 11(4):1990;545-550.
34. Rosalki S.B., Rau D. Serum γ-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta. 39:1972;41-47.
35. Bagrel A., D'Houtaud A., Gueguen R., Siest G. Relations between reported alcohol consumption and certain biological variables in an " unselected" population. Clin Chem. 25(7):1979;1242-1246.
36. Barouki R., Chobert M.N., Finidori J., Aggerbeck M., Nalpas B., Hanoune J. Ethanol effects in a rat hepatoma cell line: induction of γ-glutamyltransferase. Hepatology. 3(3):1983;323-329.
37. Sunderman W. The clinical biochemistry of 5′-nucleotidase. Ann Clin Lab Sci. 20(2):1990;123-139.
38. Goldberg D.M. 5′Nucleotidase: recent advances in cell biology, methodology and clinical significance. Digestion. 8(1):1973;87-99.
39. Reichling J., Kaplan M. Clinical use of serum enzymes in liver disease. Dig Dis Sci. 33(12):1988;1601-1614.
40. Belfield A., Goldberg M. Application of a continous spectrophotometric assay for 5′nucleotidase activity in normal subjects and patients with liver and bone disease. Clin Chem. 15(10):1969;931-939.
41. Panteghini M. Electrophoretic fractionation of 5′-nucleotidase. Clin Chem. 40(2):1994;190-196.
42. Connell M., Dinwoodie A. Diagnostic use of serum alkaline phosphatase isoenzymes and 5′-nucleotidase. Clin Chim Acta. 30:1970;235-241.
43. Ellis G., Goldberg D.M., Spooner R.J., Ward A.M. Serum enzyme tests in disease of the liver and biliary tree. Am J Clin Pathol. 70(2):1978;248-258.
44. Pagani F., Panteghini M. 5′-nucleotidase in the detection of increased activity of the liver form of alkaline phosphatase in serum. Clin Chem. 47(11):2001;2046-2048.
45. Wilson J.W. High serum levels of alkaline phosphatase are associated with cancer in cholestatic jaundice. Aust N Z J Surg. 55(5):1985;453-454.
46. Pasanen P., Pikkarainen P., Alhava E., Partanen K., Penttila I. Value of serum alkaline phosphatase, aminotransferases, gamma-glutamyl transferase, leucine aminopeptidase, and bilirubin in the distinction between benign and malignant diseases causing jaundice and cholestasis: results of a prospective study. Scan J Clin Lab Invest. 53:1993;35-39.
47. Sapey T., Mendler M.H., Guyader D., Morio O., Corbinais S., Deugnier Y. et al. Respective value of alkaline phosphatase, gamma-glutamyl transpeptidase and 5′ nucleotidase serum activity in the diagnosis of cholestasis: a prospective study of 80 patients. J Clin Gastroenterol. 30(3):2000;259-263.
48. Versland M.R., Wu G.Y., Gorelick F.S., Larkin J.M. Serologic assay for secretory component distinguishes mechanical from hepatocellular cholestasis in humans. Dig Dis Sci. 42:1997;2246-2253.
49. Gordon T. Factors associated with serum alkaline phosphatase. Arch Pathol Lab Med. 117:1993;187-190.
50. Bayer P.M., Hotschek H., Knoth E. Intestinal alkaline phosphatase and the ABO blood group system-a new aspect. Clin Chim Acta. 108:1980;81-87.
51. Skurtveit S., Tverdal A. Sex differences in gamma-glutamyltransferase in people aged 40-42 years in two Norwegian counties. Drug Alcohol Depend. 67:2002;95-98.
52. Salvaggio A., Periti M., Miano L., Tavanelli M., Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem. 37(5):1991;720-723.